Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

39.10
+0.27440.71%
Post-market: 39.08-0.0200-0.05%19:30 EDT
Volume:2K
Turnover:85.60K
Market Cap:96.57M
PE:- -
High:39.10
Open:38.94
Low:38.82
Close:38.83
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.20
T/O Rate:0.09%
Dividend:0.33
Dividend Rate:0.83%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AbbVie Targets Key Lung Cancer Market With New Phase 3 ABBV-1480 Trial

TIPRANKS
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

Abbvie : BNP Paribas Raises Target Price to $247 from $218

THOMSON REUTERS
·
Aug 11

EW Scripps is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Aug 11

Analysts Offer Insights on Real Estate Companies: Cherry Hill Mortgage (CHMI) and Ventas (VTR)

TIPRANKS
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

Healthpeak Properties Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 11

Enanta Pharmaceuticals Q3 Revenue Misses Estimates, Hurt by Lower Royalties

Reuters
·
Aug 11

Enanta FY26 Q3 Net Loss Widens to $19.5 Million; Revenue Falls to $14.4 Million

Reuters
·
Aug 11

MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

TIPRANKS
·
Aug 11

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Apogee Net Loss Widens to $85.85 Million in Q2 FY26; R&D Expenses Rise to $67.3 Million

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10